Yüksel Ürün: Novel radiopharmaceuticals for GU cancers
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X about a recent paper by Martina Sollini et al. published in European Urology.
“Novel radiopharmaceuticals are advancing diagnostic and therapeutic options for GU cancers, especially prostate.
Exciting future ahead with promising accuracy and efficacy!”
“Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers”
Authors: Martina Sollini, Jeremie Calais, Arturo Chiti, Scott Tagawa, Michael Hofman et al.
More posts featuring Yüksel Ürün.
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023